Iantech

IanTech, now operating as Carl Zeiss Meditec Cataract Technology Inc., was a medical technology firm focused on developing solutions for micro-interventional cataract surgery. The company was privately held and headquartered in Reno, Nevada. A significant milestone in the company's history was its acquisition by Carl Zeiss Meditec, a global medical technology company. The agreement was announced in October 2018 and finalized in December 2018, integrating IanTech's technology into Zeiss's portfolio of cataract surgical solutions.

The company's primary product is the miLOOP Lens Fragmentation Device. This device was engineered as an alternative to traditional phacoemulsification technology, which has been the standard in cataract surgery for over five decades. The miLOOP utilizes a micro-thin, super-elastic, and self-expanding nitinol filament. This technology is designed to allow surgeons to achieve full-thickness lens fragmentation for any grade of cataract. A key benefit of this approach is the reduction of intraocular ultrasonic vibrations and the amount of phaco power needed during the procedure, which can simplify challenging cases and reduce risks for patients. The business model centered on the development and sale of these specialized ophthalmic tools to ophthalmologists and surgeons, aiming to establish a new standard of care in cataract surgery.

Dr. John Berdahl, a board-certified ophthalmologist specializing in cataract, corneal, and glaucoma surgery, is associated with the company's founding. His work is characterized by identifying unmet needs in clinical practice and developing solutions. Dr. Berdahl's extensive research includes minimally invasive glaucoma surgery and refractive laser-assisted cataract surgery. His background as a practicing surgeon provided direct insight into the challenges of cataract procedures, which informed the development of IanTech's technology. Before the acquisition, Brian Walsh served as the CEO of IanTech.

Keywords: micro-interventional cataract surgery, miLOOP, lens fragmentation, phacoemulsification alternative, nitinol filament technology, ophthalmic surgical tools, Carl Zeiss Meditec, ophthalmology, eye surgery technology, medical device, cataract treatment, surgical ophthalmology, John Berdahl, Brian Walsh, intraocular, surgical instruments, vision care, eye health, medical technology acquisition